Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
Myriad Genetics Inc.   (ticker: MYGN)
Quote:() Quotes on: Yahoo | Google
5 day's Perf: 100%
1 Month Perf: 100%
3 Month Perf: 100%
YTD Perf: 100%
1 Year Perf: 100%
Stock chart
Useful Quick Links for MYGN
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :          Buy          (Click Here For Details)
INSIDERS' Score: 60
0 100 60
Latest 1 month: 0 0
Latest 6 Months: 5,860 11,627
52 Weeks: 12,860 245,339
Gurus' Indicator :          Buy          (Click Here For Details)
GURUS' Score: 60
0 100 60
Current Holdings: 2,930,083
Previous Holdings: 2,661,320
Change: 10.10%
Institutions' Indicator :          Hold          (Click Here For Details)
0 100 50
Current Holdings: 62,711,648
Previous Holdings: 62,301,120
Change: 0.66%
News And Links For The Group (Contribute a link)
[MYGN]   AstraZeneca's Latest FDA Approval Provides Hope For Pancreatic Cancer Patients  (Seeking Alpha)   9-Jan-20 16:44
[MYGN]   Invitae - Bringing Genetic Testing To Everyone  (Seeking Alpha)   27-Nov-19 08:27
[MYGN]   Breaking Down The Invitae Short (Podcast Transcript)  (Seeking Alpha)   18-Nov-19 10:30
[MYGN]   Breaking Down The Invitae Short (Podcast)  (Seeking Alpha)   11-Nov-19 07:00
[MYGN]   Invitae Short Thesis: The WeWork Of Genetics  (Seeking Alpha)   11-Oct-19 10:30
[MYGN]   Myriad Genetics: The Genesight Bull Case Is Falling Apart, 45% Downside Risk  (Seeking Alpha)   24-Sep-19 08:30
[MYGN]   The Disciplined Investor Considers Capturing Profit In Myriad Genetics  (Seeking Alpha)   7-Aug-19 13:51
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*